102 related articles for article (PubMed ID: 6396561)
41. High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis.
Iacoboni SJ; Plunkett W; Kantarjian HM; Estey E; Keating MJ; McCredie KB; Freireich EJ
J Clin Oncol; 1986 Jul; 4(7):1079-88. PubMed ID: 3459811
[TBL] [Abstract][Full Text] [Related]
42. Phase II trial of vindesine in advanced neoplastic disease.
Stambaugh JE
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
[No Abstract] [Full Text] [Related]
43. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
Saiers JH; Slavik M; McKinney DR
Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
[No Abstract] [Full Text] [Related]
44. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
Wander HE; Nagel GA
Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
[TBL] [Abstract][Full Text] [Related]
45. [Vindesine in oral cancers].
Szpirglas H; Marneur M; Vaillant JM
Presse Med; 1985 Feb; 14(7):405-7. PubMed ID: 3157128
[TBL] [Abstract][Full Text] [Related]
46. An EORTC phase II study of vindesine in advanced prostate cancer.
Jones WG; Fosså SD; Denis L; Coninx P; Glashan RW; Akdas A; De Pauw M
Eur J Cancer Clin Oncol; 1983 May; 19(5):583-8. PubMed ID: 6683629
[TBL] [Abstract][Full Text] [Related]
47. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
[TBL] [Abstract][Full Text] [Related]
48. [Blast crisis in chronic myeloid leukemia. Results with vindesine and prednisolone].
Nitsche D; Tschurtschenthaler G; Stöger M; Michlmayr G
Dtsch Med Wochenschr; 1985 Dec; 110(50):1936-9. PubMed ID: 3865760
[TBL] [Abstract][Full Text] [Related]
49. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
[TBL] [Abstract][Full Text] [Related]
50. Meningeal leukemia following lymphoid blast crisis in chronic myeloid leukemia: therapeutic implications.
Cazzola M; Nalli G; Brusamolino E; Daccò M; Ghizzi A; Molinari E; Tagliabue A
Tumori; 1982 Jun; 68(3):257-63. PubMed ID: 6958115
[TBL] [Abstract][Full Text] [Related]
51. Experience on the treatment of chronic myelocytic leukaemia (CML) in blastic crisis.
Mandelli F; Amadori S; Alimena G; Annino L; Nardelli S; Papa G
Scand J Haematol; 1977 Nov; 19(5):496-502. PubMed ID: 271352
[TBL] [Abstract][Full Text] [Related]
52. Treatment of acute lymphoblastic leukemia in adults with combination chemotherapy incorporating vindesine and prednisolone.
Saito Y; Uzuka Y
Tohoku J Exp Med; 1983 Apr; 139(4):421-2. PubMed ID: 6575488
[TBL] [Abstract][Full Text] [Related]
53. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
[TBL] [Abstract][Full Text] [Related]
54. Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.
Wong PP; Yagoda A; Currie VE; Young CW
Cancer Treat Rep; 1977 Dec; 61(9):1727-9. PubMed ID: 340038
[No Abstract] [Full Text] [Related]
55. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
Marthé G; Misset JL; de Vassal F; Hayat M; Gouveia J; Machover D; Belpomme D; Schwarzenberg L; Ribaud P; Pico JL; Musset M; Jasmin C; de Luca L
Nouv Presse Med; 1978 Feb; 7(7):525-8. PubMed ID: 273888
[TBL] [Abstract][Full Text] [Related]
56. Phase I and II studies of vindesine.
Valdivieso M
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():31-7. PubMed ID: 7438119
[No Abstract] [Full Text] [Related]
57. Vindesine in the treatment of malignant mesothelioma: a phase II study.
Kelsen D; Gralla R; Cheng E; Martini N
Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
[TBL] [Abstract][Full Text] [Related]
58. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
Hutcheon AW; Palmer JB; Pratt MA; Clark RA
Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
[No Abstract] [Full Text] [Related]
59. Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion.
Ohnuma T; Greenspan EM; Holland JF
Cancer Treat Rep; 1980 Jan; 64(1):25-30. PubMed ID: 6929728
[TBL] [Abstract][Full Text] [Related]
60. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
